A Coverage Policy Analysis on TMS is now available, providing clinicians and policy leaders with information on the comparative clinical effectiveness and value of TMS in treating patients with resistant-depression. This Coverage Policy Analysis  includes the following components:

  • Summary of CEPAC votes on TMS
  • A supplementary report on TMS
  • New England Medicare coverage policy for TMS
  • Overview of CEPAC